USPTO serial 75813304
CDS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WILLIAMS KELLY L.
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CDS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martin Fleit
MARTIN FLEIT MARTIN FLEIT, PA520 BRICKELL KEY DRMIAMI, FL 33131-1660UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical reagents, lytic reagents, quench reagents, enzyme reagents, rinsing reagents and cleaning reagents all for use with hematology, and/or chemical analytical automated and semi-automated study and analysis instruments, machines and systems used in diagnostic, industrial, biological, and cytology laboratories all for scientific or research use; reagents, diluents and buffers as packaged in ready use dispensing packages for scientific or research use; dyes and stains for microscopic specimen slides and flow cytometry used in diagnostic or scientific research; microspheres, fluoroscopes and monodispersed particles for use as standards, calibrators and carrier receptor sites employed with cytology and particle study and analysis instruments and systems used in the biological, industrial, and/or academic fields for scientific or research use; whole blood hematology reference control solutions for calibration in electronic particle laboratory analysis for diagnostic, scientific or research use; diluents, standards, reference control compositions, sheath fluids for scientific and research use; diagnostic laboratory reagents for hemoglobin testing for scientific and research use; reagents for use with automatic chemical analysis instruments in biological, chemical, industrial, and clinical laboratories for scientific or research use | ACTIVE | Jul 13, 1999 |
| 005 | buffer reagents, diluent reagents, and stopping reagents for medical laboratory research use; whole blood lyophilizing comprising individual containers of immunolyse reagent, of fixative reagent, of stabilizer reagent and of buffered saline solution for cell suspension preparation of whole blood and bone marrow aspirate studies for medical laboratory use; kits for calibrating and/or control of in vitro diagnostic electronic hematology analysis instruments comprising vials of reference calibrator and/or control reagents for medical laboratory use; kits for determining white blood cell differentiation in vitro diagnostic electronic hematology analysis instruments comprising individual containers of diluent reagents, lytic reagents, enzymatic reagents, quench reagents and /or control reagents | ACTIVE | Jul 13, 1999 |
| 016 | newsletter dealing with in vitro diagnostic hematology instruments and reagents; product catalogs in the fields of particle study and analysis, hematology, cytology, instrumentation and related biological, medical, clinical, industrial and applications technology; customer oriented periodically issued newsletter in the fields of particle study and analysis, hematology, cytology, instrumentation and related biological, medical, clinical, industrial and applications technology; periodically issued corporate newsletter dealing with matters of corporate employee interest in the field of particle study and analysis, hematology,cytology, instrumentation and related biological, medical, clinical, industrial and applications technology, corporate activities and policies and employee activities | ACTIVE | — |
| 037 | operating multistate technology and support service providing for repair of particle study and analysis instruments, cytometry instruments, hematology instruments, accessories and components thereof, in the medical, biological, industrial, clinical laboratory and research fields; operating multistate technology and support service for maintenance of particle study and analysis instruments, cytometry instruments, hematology instruments, accessories and components thereof | ACTIVE | May 7, 1999 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CLINICAL DIAGNOSTIC SOLUTIONS, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 037
- Similar marks named CDS
- Prosecution event ABN2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2000 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 19, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 14, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2000 | DOCK | ASSIGNED TO EXAMINER | — |